Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
This study was withdrawn before enrollment.
Multiple locations, including Ballarat
This study has finished and is no longer accepting participants.
In CaenAlliances to Disseminate Addiction Prevention and Treatment (ADAPT): A Statewide Learning Health System to Reduce Substance Use Among Justice-Involved Youth in Rural Communities
This study has finished and is no longer accepting participants.
In IndianapolisA Phase I/II, Prospective, Randomized, Double-Blind, PlAcebo-ControLled Trial to EvAluate the Efficacy of Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.(ALAUNUS)
This study has finished and is no longer accepting participants.
In HarlingenAllopurinol Add-on Treatment for Refractory Mania
Read the official source — NCT00643123A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania
This study has finished and is no longer accepting participants.
In Los AngelesAllopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
Read the official source — NCT01092221Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Beer-YaakovAllopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
Read the official source — NCT00864825Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Bat YamAn Open Label, Naturalistic Study With Allopurinol Augmentation for Prevention of Mania in Bipolar Disorder
This study ended early.
In Los AngelesAloud Real-time Reading of ICU Diaries for Prevention of Negative Post-ICU Psychological Outcomes: A Feasibility Study
This study has finished and is no longer accepting participants.
In RochesterAlpha-1 Blockade for Alcohol Use Disorder (AUD)
Read the official source — NCT04135846A Focus on Alpha-1 Blockade as a Novel Pharmacological Treatment for AUD
This study is no longer accepting new participants.
In ProvidenceAlpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
This study has finished and is no longer accepting participants.
In New HavenAlpha-lipoic Acid Adjunctive Therapy in Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial
This study has finished and is no longer accepting participants.
In FortalezaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.